H Cyte, Inc. HCYTD
We take great care to ensure that the data presented and summarized in this overview for H-CYTE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in HCYTD
Top Purchases
Top Sells
About HCYTD
Insider Transactions at HCYTD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2024
|
Todd R Wagner > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
303,107
+46.79%
|
-
|
|
Jan 16
2024
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,168
+30.95%
|
-
|
|
Mar 21
2022
|
Frederick J Lynch > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
8,321,785
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 23
2022
|
Todd R Wagner > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
41,608,884
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 23
2022
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
693,477
+4.1%
|
$0
$0.01 P/Share
|
|
Jun 29
2021
|
Michael Yurkowsky Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
69,500
-0.53%
|
$0
$0.18 P/Share
|
|
Jul 23
2020
|
J Rex Farrior Iii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
15,518,111
+50.0%
|
$0
$0.41 P/Share
|
Last 12 Months Summary
Buy / Acquisition
316K
Shares
From
2
Insiders
| Conversion of derivative security | 316K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders